Table 2.
Anthropometric and clinical characteristics of the study sample according to the risk of sarcopenia.
| Variables | Not at Risk of Sarcopenia (n = 126) |
At Risk of Sarcopenia (n = 12) |
p |
|---|---|---|---|
| Women (n, %) | 38 (30) | 9 (75) | 0.003 |
| Age (years) | 72 ± 5 | 72 ± 4 | 0.954 |
| Body weight (Kg) | 81 ± 12 | 75 ± 13 | 0.085 |
| BMI (Kg/m2) | 29 ± 5 | 29 ± 5 | 0.975 |
| Waist circumference (cm) | 102 ± 11 | 100 ± 12 | 0.508 |
| Duration of diabetes (years) | 18 ± 9 | 21 ± 10 | 0.294 |
| Alcohol consumption (n, %) | 80 (63) | 5 (47) | 0.231 |
| Smoker (n, %) | 29 (23) | 4 (33) | 0.708 |
| Glucose-lowering drugs (n, %) | 115 (91) | 12 (100) | 1.000 |
| Rapid-acting insulin (n, %) | 30 (29) | 5 (47) | 0.356 |
| Long-acting insulin (n, %) | 53 (42) | 4 (33) | 0.834 |
| Antihypertensive drugs (n, %) | 109 (87) | 10 (83) | 0.510 |
| Lipid-lowering drugs (n, %) | 107 (85) | 10 (83) | 0.602 |
| Retinopathy (%) | 25 (20) | 2 (17) | 1.000 |
| Neuropathy (%) | 24 (19) | 6 (50) | 0.027 |
| Nephropathy (%) | 31 (25) | 2 (17) | 0.719 |
| Cardiovascular diseases (%) | 47 (37) | 2 (17) | 0.211 |
Data are expressed as the mean ± standard deviation (SD), number (%). BMI: body mass index.